1. Home
  2. TLSI vs SGC Comparison

TLSI vs SGC Comparison

Compare TLSI & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

N/A

Current Price

$2.42

Market Cap

250.0M

Sector

Health Care

ML Signal

N/A

Logo Superior Group of Companies Inc.

SGC

Superior Group of Companies Inc.

N/A

Current Price

$13.89

Market Cap

214.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
TLSI
SGC
Founded
2010
1920
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
250.0M
214.8M
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
TLSI
SGC
Price
$2.42
$13.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$10.00
★ $18.67
AVG Volume (30 Days)
★ 192.8K
28.8K
Earning Date
11-10-2026
11-09-2026
Dividend Yield
N/A
★ 4.19%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.31
Revenue
$45,151,000.00
★ $566,184,000.00
Revenue This Year
$14.10
$3.00
Revenue Next Year
$37.87
$5.29
P/E Ratio
★ N/A
$43.89
Revenue Growth
★ 53.41
0.09
52 Week Low
$2.20
$8.30
52 Week High
$7.95
$14.70

Technical Indicators

Market Signals
Indicator
TLSI
SGC
Relative Strength Index (RSI) 23.71 56.60
Support Level $2.20 $11.74
Resistance Level $4.35 $14.57
Average True Range (ATR) 0.31 0.78
MACD -0.09 0.05
Stochastic Oscillator 6.72 58.97

Price Performance

Historical Comparison
TLSI
SGC

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

About SGC Superior Group of Companies Inc.

Superior Group Of Companies Inc designs apparel products. The company operates through three segments: i) The Branded Products segment, under the brands BAMKO and HPI, produces and sells customized merchandising solutions, promotional products, and branded uniform programs. ii) The Healthcare Apparel segment, under the brands Wink and Fashion Seal Healthcare, manufactures and sells healthcare apparel including scrubs, lab coats, protective apparel, and patient garments. iii) The Contact Centers segment, through The Office Gurus entities, provides outsourced, nearshore, and onshore business process outsourcing (BPO), contact center, and call-center support services to customers in North America. The majority of the company's revenue is derived from the Branded Products segment.

Share on Social Networks: